AURIGA LABORATORIES, INC. 4
4 · AURIGA LABORATORIES, INC. · Filed Apr 24, 2007
Insider Transaction Report
Form 4
AURIGA LABORATORIES, INC.ARGA.OB
Wagoner Dayne
Director
Transactions
- Sale
Common Stock
2007-04-20$1.69/sh−100$169→ 3,005,911 total(indirect: See Footnote) - Sale
Common Stock
2007-04-23$1.28/sh−300$384→ 3,005,411 total(indirect: See Footnote) - Sale
Common Stock
2007-04-23$1.30/sh−500$650→ 3,004,911 total(indirect: See Footnote) - Sale
Common Stock
2007-04-20$1.49/sh−200$298→ 3,010,711 total(indirect: See Footnote) - Sale
Common Stock
2007-04-23$1.50/sh−1,100$1,650→ 3,001,091 total(indirect: See Footnote) - Sale
Common Stock
2007-04-20$1.64/sh−1,700$2,788→ 3,006,711 total(indirect: See Footnote) - Sale
Common Stock
2007-04-20$1.50/sh−2,300$3,450→ 3,008,411 total(indirect: See Footnote) - Sale
Common Stock
2007-04-23$1.27/sh−200$254→ 3,005,711 total(indirect: See Footnote) - Sale
Common Stock
2007-04-23$1.40/sh−100$140→ 3,002,591 total(indirect: See Footnote) - Sale
Common Stock
2007-04-23$1.37/sh−720$986→ 3,003,191 total(indirect: See Footnote) - Sale
Common Stock
2007-04-20$1.65/sh−500$825→ 3,006,211 total(indirect: See Footnote)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on September 18, 2006.
- [F2](a) 2,785,991 shares are held indirectly by the reporting person through The Wagoner Family Trust; (b) a warrant to purchase 150,000 shares is held indirectly by the reporting person through The Wagoner Family Trust; and (c) the remaining shares are owned directly by the reporting person.